WASHINGTON -- Patients with IgG4-related disease appeared to benefit from inebilizumab (Uplizna), currently approved for ...

Q3 2024 Earnings Call Transcript November 14, 2024 Operator: Good day, and thank you for standing by. Welcome to the Q3 2024 Invivyd Earnings Conference Call. At this time, all participants are in a ...

OS Therapies, Inc. ("OS Therapies" or "the Company"), a clinical-stage cancer immunotherapy and antibody drug conjugate biotechnology company, today reported financial results for the third quarter of ...

It just feels like it didn’t have to come to this. I feel like, as a father, I waited way too long for insurance to give us a ...

Eight participants achieved HBsAg loss at any time.Two participants met criteria for functional cure. Two participants who discontinued NUC ...

One popular brand boasts the supplement can ‘revive whole body health’. But can an aesthetically packaged powder actually ...

The European Medicines Agency re-examined clinical data of a subset of patients with one or no copies of the APOE4 gene ...

Researchers at Stanford Medicine found that people who produce more sialic acid tend to have milder flu symptoms.

DKSH Business Unit Technology has announced a strategic collaboration with Abcam, a global life science company ...

In terms of liquidity and interest, the mean open interest for Biogen options trades today is 1866.8 with a total ...

Louisiana's climate fosters a variety of allergens, like pollen and mold. And as an "allergy capital," the city rarely gets ...

50% of patients (3/6) with baseline HBsAg <1000 IU/mL achieved a functional cure (defined as sustained HBsAg loss and HBV DNA ...